Zhenghong Yu Selected Research

Zhenghong Yu Research Topics

Disease

13	Neoplasms (Cancer) 01/2023 - 07/2004
8	Breast Neoplasms (Breast Cancer) 12/2023 - 01/2013
3	Stomach Neoplasms (Stomach Cancer) 07/2023 - 08/2020
2	Critical Illness (Critically Ill) 01/2022 - 01/2021
2	Lung Neoplasms (Lung Cancer) 12/2015 - 05/2007
1	Glioma (Gliomas) 11/2022
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 08/2021
1	Malnutrition (Nutritional Deficiencies) 01/2021
1	Pain (Aches) 12/2019
1	Osteosarcoma (Osteogenic Sarcoma) 06/2019
1	Intervertebral Disc Degeneration 01/2018
1	Triple Negative Breast Neoplasms 01/2017
1	Congenital Abnormalities (Deformity) 01/2016
1	Hepatitis B 01/2016
1	Hepatocellular Carcinoma (Hepatoma) 01/2016
1	Inflammation (Inflammations) 01/2016
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2016
1	Neoplasm Metastasis (Metastasis) 01/2016
1	Tuberculosis (Tuberculoses) 01/2016
1	Spinal Tuberculosis (Pott's Disease) 01/2016
1	B-Cell Lymphoma (Lymphoma, B Cell) 12/2015
1	Adenocarcinoma of Lung 12/2015
1	Prostatic Neoplasms (Prostate Cancer) 07/2004

Drug/Important Bio-Agent (IBA)

4	Biomarkers (Surrogate Marker)IBA 12/2023 - 05/2007
3	Interleukin-2 (IL2)IBA 01/2022 - 01/2021
3	Interleukin-8 (Interleukin 8)IBA 01/2022 - 01/2021
3	CytokinesIBA 08/2021 - 01/2018
3	Proteins (Proteins, Gene)FDA Link 02/2020 - 06/2015
3	DNA (Deoxyribonucleic Acid)IBA 01/2016 - 07/2004
2	Messenger RNA (mRNA)IBA 11/2022 - 12/2015
2	RNA (Ribonucleic Acid)IBA 11/2022 - 12/2019
2	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2021
2	ProcalcitoninIBA 01/2022 - 08/2021
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 08/2021
2	protein kinase C nuIBA 01/2021 - 01/2017
2	Estrogen ReceptorsIBA 02/2020 - 06/2015
2	Tamoxifen FDA LinkGeneric 02/2020 - 01/2017
2	Estrogens (Estrogen)FDA Link 06/2015 - 01/2013
1	Prokaryotic Initiation Factor-2IBA 12/2023
1	AntigensIBA 12/2022
1	Cell Adhesion MoleculesIBA 11/2022
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 11/2022
1	Interleukin-10 (Interleukin 10)IBA 01/2022
1	C-Reactive ProteinIBA 08/2021
1	InterleukinsIBA 08/2021
1	Lysine (L-Lysine)FDA Link 08/2020
1	Histones (Histone)IBA 08/2020
1	Histone MethyltransferasesIBA 08/2020
1	Histone-Lysine N-MethyltransferaseIBA 08/2020
1	Sincalide FDA Link 02/2020
1	Mitogen-Activated Protein KinasesIBA 12/2019
1	Phenobarbital (Luminal)FDA Link 12/2019
1	Phosphotransferases (Kinase)IBA 12/2019
1	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2019
1	Immune Checkpoint InhibitorsIBA 06/2019
1	AntibodiesIBA 06/2019
1	acetamideIBA 06/2019
1	Protein Kinase D2IBA 01/2019
1	Peptide Hydrolases (Proteases)FDA Link 01/2018
1	Histone Deacetylase 6IBA 01/2017
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2017
1	tubacinIBA 01/2017
1	17- (dimethylaminoethylamino)- 17- demethoxygeldanamycinIBA 01/2017
1	Sorafenib (BAY 43-9006)FDA Link 01/2016
1	Antiviral Agents (Antivirals)IBA 01/2016
1	Cisplatin (Platino)FDA LinkGeneric 12/2015
1	Pemetrexed (MTA)FDA Link 12/2015
1	crocinIBA 12/2015
1	Aromatase InhibitorsIBA 06/2015
1	Progesterone FDA LinkGeneric 06/2015
1	Glycoproteins (Glycoprotein)IBA 02/2015
1	Complementary DNA (cDNA)IBA 01/2013
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2013

Therapy/Procedure

6	Therapeutics 01/2023 - 02/2015
2	Gastrectomy 07/2023 - 06/2023
1	Drug Therapy (Chemotherapy) 11/2022
1	Nutritional Support (Artificial Feeding) 01/2021
1	Injections 12/2019
1	Pedicle Screws 01/2016
1	Debridement 01/2016
1	Hepatectomy 01/2016
1	Liver Transplantation 01/2016